CND Life Sciences brings global headquarters to Scottsdale
CND Life Sciences, a medical technology company, announced the grand opening of its global headquarters in Scottsdale, Arizona.
Source: azbigmedia.com
📰 Syn One Test News
Page 2 - Syn One Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Syn One Test. Real-time updates on events, politics, business and more.
Cutting Edge Medical Technology Company CND Life Sciences Announces Grand Opening of Global Headquarters and Laboratories in Scottsdale
/PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of reliable skin-based tests to help clinicians diagnose...
Source: prnewswire.com
Cutting Edge Medical Technology Company CND Life Sciences Announces Grand Opening of Global Headquarters and Laboratories in Scottsdale
Company Focuses on Innovative Diagnosis and Treatment of Neurodegenerative DiseasesSCOTTSDALE, Ariz., March 30, 2023 /PRNewswire/ -- CND Life Scie...
United States Mary Parra Joan Koerber Walker Terri Spitz David Ortega National Institute Of Neurological Disorders
Source: businessinsider.com
I can name my demon, says patient whose neurologist confirmed Parkinson's with new biopsy test
Georgia patient Chris Griffin says the Syn-One test biopsy results brought him peace of mind, and helped him make lifestyle changes and treat his Parkinson’s disease early.
Source: gpb.org
CND Life Sciences Partners with Soleo Health to Broaden the Awareness and Availability of CND's Cutaneous Neurodiagnostic Tests
/PRNewswire/ -- CND Life Sciences (http://cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and...
Source: prnewswire.com
Which REM Sleep Behavior Disorder Patients Will Develop Parkinson's? CND Works on Skin Biopsy Test for Early Detection of Synucleinopathies
CND Life Sciences is studying its Syn-One Test in hopes of predicting the conversion of RBD to a more advanced synucleinopathy.
United States Mitchell Miglis Todd Levine American Prodromal Synucleinopathy Consortium Stroke Of The National Institutes Health Phase Ii Small Business Innovation Research
Source: sleepreviewmag.com
CND Life Sciences Awarded Third NIH SBIR Grant to Study the Syn-One Test® in Patients Diagnosed with REM Sleep Behavior Disorder (RBD)
/PRNewswire/ -- CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition...
United States Mitchell Miglis Todd Levine Jen Marnowski American Prodromal Synucleinopathy Consortium Phase Ii Small Business Innovation Research
Source: prnewswire.com
CND Life Sciences Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias
/PRNewswire/ -- CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition...
United States Angela Taylor Todd Levine Kendall Swanson Phase Ii Small Business Innovation Research Marketing Communications
Source: prnewswire.com
CND LIFE SCIENCES ADDS TWO ACCOMPLISHED PATHOLOGISTS TO LEADERSHIP TEAM
/PRNewswire/ -- CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and...
Source: prnewswire.com
CND Life Sciences Raises $5.0M in Series Seed 2 Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com